Mineralys Therapeutics (MLYS) Interest Coverage Ratio (2022 - 2025)

Mineralys Therapeutics (MLYS) has 4 years of Interest Coverage Ratio data on file, last reported at 0.26 in Q4 2025.

• For the quarter ending Q4 2025, Interest Coverage Ratio rose 59.61% year-over-year to 0.26; the trailing twelve-month figure through Dec 2025 stood at 1.17 (up 51.56% YoY), and the FY2025 full-year result was 1.17, up 51.56% from the prior year.
• Interest Coverage Ratio improved to 0.26 in Q4 2025, from 0.65 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 0.26 in Q4 2025 to a low of 32.33 in Q4 2023.
• A 4-year average of 8.47 and a median of 0.65 in 2022 frame the typical range for Interest Coverage Ratio.
• Across the five-year window, Interest Coverage Ratio plunged 4927.61% in 2023 and jumped 98.0% in 2024, its largest moves.
• Tracing MLYS's Interest Coverage Ratio over 4 years: stood at 0.64 in 2022, then sank by 4927.61% to 32.33 in 2023, then jumped by 98.0% to 0.65 in 2024, then soared by 59.61% to 0.26 in 2025.
• Business Quant data shows MLYS's Interest Coverage Ratio at 0.26 in Q4 2025, 0.65 in Q4 2024, and 32.33 in Q4 2023.